The Latest Breaking News from Abbott Laboratories

With geopolitical tensions rising, here are three stocks from different sectors that have the ability to weather this storm.

Spinoffs are value creating investment opportunities. You should be looking at them

Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on from the pandemic.

If you’re one of the millions of Americans taking the prescription medication Humira, get ready to add the word biosimilars to your conversations with your doctor.

Despite the cooling down of inflation, a Fed rate cut is not in sight. Amid recessionary concerns, investing in medical stock Abbott Laboratories (ABT) could be wise given its sound financials and the inherent stability of the medical sector. Let’s take a look at some of the company’s key metrics….

Abbott Laboratories reported better-than-expected first-quarter sales despite a slowdown from its Covid test segment. ABT stock jumped.

The stock market will likely stay under pressure this year, with stubborn inflation and elevated interest rates. However, the Fed’s decision could largely be influenced by concerns about the recent banking crisis. Amid such uncertainty, fundamentally sound stocks Johnson & Johnson (JNJ), Abbott Laboratories (ABT), and Humana (HUM) could be…

The healthcare industry is expanding, fueled by the increasing demand and advancements such as personalized medicines and telehealth. Hence, fundamentally strong healthcare stocks Abbott Laboratories (ABT), Centene (CNC), and McKesson (MCK) might be worth buying in 2023. Read more.

Dexcom stock toppled Monday after the FDA cleared Abbott Laboratories to pair its body-worn glucose monitors with automated insulin pumps.

An aging population and innovation in treatments should continue to bode well for the healthcare sector for the longer term. With healthcare being vital for well-being and wallet, one could invest in quality healthcare stocks Thermo Fisher Scientific (TMO), Abbott Laboratories (ABT), and Centene Corp. (CNC). Read on….

Abbott Laboratories is facing another investigation into its role in last year’s baby formula shortage that left millions of American families scrambling for vital nutrition products.